Malpractice Risk — Identify malpractice risk scenarios and required compliance behaviors to reduce liability

The concept of pharmacy malpractice evolved alongside the broader transformation of American tort law and the professionalization of pharmacy practice. For much of the nineteenth century, pharmacists—then commonly called apothecaries or druggists—operated with minimal regulatory oversight, and injured patients had few legal avenues for redress unless they could prove intentional harm. The shift toward a negligence-based standard of care fundamentally restructured the legal landscape, requiring pharmacists to meet an objective professional benchmark rather than simply avoid willful misconduct. This transformation accelerated during the twentieth century as pharmacists assumed expanded clinical roles, drug regimens became more complex, and state boards of pharmacy adopted increasingly detailed practice acts that codified minimum compliance behaviors.

Against this backdrop, a central question emerges for every pharmacy practitioner preparing for the MPJE: What specific scenarios most commonly give rise to malpractice liability, and what compliance behaviors does the law require to reduce that risk? Answering this question demands an integrated understanding of tort law principles, state pharmacy practice acts, federal regulations, and the real-world dispensing environment.

Pharmacy malpractice is a specialized form of professional negligence, meaning it arises when a licensed pharmacist fails to exercise the degree of care, skill, and learning expected of a reasonably prudent pharmacist under the same or similar circumstances, and that failure proximately causes harm to a patient. Unlike ordinary negligence—where the defendant is held to a "reasonable person" standard—malpractice claims evaluate the defendant's conduct against the professional standard of care established by expert testimony, published guidelines, and regulatory mandates. Every successful malpractice claim requires the plaintiff to establish four distinct legal elements, each of which must be proven by a preponderance of the evidence.

Two additional doctrines frequently appear in pharmacy malpractice litigation. Respondeat superior holds the employer—often a corporate pharmacy chain—vicariously liable for the negligent acts of its employee pharmacists committed within the scope of employment. Negligence per se applies when the pharmacist violates a statute or regulation designed to protect the class of persons to which the plaintiff belongs; in such cases, the violation itself may establish the breach element without additional expert testimony. These doctrines significantly expand exposure for both individual pharmacists and their employers.

The diagram above demonstrates a critical strategic insight: compliance behaviors do not merely satisfy regulatory requirements—they function as affirmative legal defenses. When a pharmacist performs a thorough drug utilization review (DUR) and provides patient counseling, those actions directly negate the breach element because they demonstrate adherence to the standard of care. When those actions are properly documented, they create contemporaneous evidence that can be presented at trial, often years after the event in question. Pharmacists should internalize this relationship: every compliance step is simultaneously a clinical obligation and a layer of legal protection.

High-Risk Dispensing Scenarios

Malpractice risk is not distributed evenly across all pharmacy activities. Certain scenarios generate a disproportionate share of claims, and understanding these high-risk situations is essential for both the MPJE and clinical practice. The most frequently litigated scenarios involve dispensing errors—wrong drug, wrong strength, wrong dosage form, or wrong patient—which collectively account for the largest category of pharmacy malpractice claims. These errors are often traceable to look-alike/sound-alike (LASA) drug name confusion, inadequate verification procedures, or staffing-related fatigue.

The second major risk category is failure to perform drug utilization review. State pharmacy practice acts universally require prospective DUR before dispensing, including screening for drug-drug interactions, therapeutic duplications, incorrect dosages, drug-disease contraindications, and drug-allergy cross-sensitivities. A pharmacist who dispenses a prescription without conducting this review—or who identifies a clinically significant interaction but fails to act on it—has committed a breach of the standard of care that satisfies the second element of a malpractice claim.

Third, failure to counsel has emerged as a significant source of liability since OBRA '90. The pharmacist's obligation extends beyond merely offering to counsel; when counseling is provided, it must be accurate, complete, and appropriate to the patient's literacy level and clinical needs. Providing incorrect information about a medication's side effects, contraindications, or proper administration constitutes an independent basis for malpractice. Fourth, failure to exercise corresponding responsibility when dispensing controlled substances—particularly when red flags suggest the prescription was not issued for a legitimate medical purpose—exposes the pharmacist to both civil liability and criminal prosecution.

Required Compliance Behaviors

• ✓ Prospective Drug Utilization Review (DUR): Screen every prescription for therapeutic appropriateness, drug interactions, allergies, correct dosage, and duplications before dispensing.
• ✓ Patient Counseling: Offer counseling on all new prescriptions (and as required by state law on refills). Include drug name, purpose, dosage, route, duration, side effects, storage, and refill information.
• ✓ Verification and Double-Check Systems: Implement systematic verification at each step—data entry, product selection, and final verification. Use barcode scanning and independent double checks for high-alert medications.
• ✓ Corresponding Responsibility for Controlled Substances: Evaluate each controlled substance prescription for legitimacy, query the state PDMP, and document resolution of any red flags before dispensing.
• ✓ Contemporaneous Documentation: Record all clinical decisions, prescriber contacts, DUR overrides, patient refusals of counseling, and error reports in the patient's pharmacy record.

Consider the following scenario: A pharmacist receives a prescription for methotrexate 2.5 mg daily for a patient with rheumatoid arthritis. The standard dosing regimen for methotrexate in rheumatoid arthritis is typically once weekly, not daily. The pharmacist fills the prescription as written without contacting the prescriber, does not perform DUR, and does not counsel the patient on the medication's serious risks. The patient takes methotrexate daily for two weeks, develops severe pancytopenia, and is hospitalized. The patient subsequently sues the pharmacist and the pharmacy.

While the elements of malpractice establish the framework for plaintiff claims, pharmacists have access to several legal defenses and practical risk mitigation strategies. Understanding these defenses is equally important for the MPJE, as questions frequently test a candidate's ability to identify which compliance behaviors would have prevented or reduced liability in a given scenario.

Pharmacy malpractice does not exist in isolation—it intersects with several advanced legal doctrines and evolving regulatory frameworks that MPJE candidates should understand at a conceptual level. The expansion of pharmacist scope of practice into areas such as immunization, collaborative drug therapy management (CDTM), prescriptive authority under protocol, and point-of-care testing has created new categories of potential liability that did not exist even a decade ago. As pharmacists assume clinical responsibilities historically reserved for physicians, the standard of care against which their conduct is measured is also evolving, and courts are beginning to apply more rigorous clinical standards to pharmacist decision-making.